Stockscreener 앱 받기
30.07
1.41%
-0.43
시간 외 거래:
30.07
전일 마감가:
$30.50
열려 있는:
$30.36
하루 거래량:
1.71M
Relative Volume:
1.61
시가총액:
$12.74B
수익:
$6.18B
순이익/손실:
$626.40M
주가수익비율:
20.95
EPS:
1.435
순현금흐름:
$848.81M
1주 성능:
-2.69%
1개월 성능:
+1.79%
6개월 성능:
-7.59%
1년 성능:
+5.03%
1일 변동 폭
$29.86
$30.47
1주일 범위
$29.86
$30.98
52주 변동 폭
$28.40
$38.79
Smith Nephew Plc Adr Stock (SNN) Company Profile
Compare SNN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
30.07 | 12.90B | 6.18B | 626.40M | 848.81M | 1.435 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-14 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2025-04-25 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-03-12 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-06 | 다운그레이드 | Berenberg | Buy → Hold |
| 2024-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-07-24 | 개시 | Deutsche Bank | Buy |
| 2024-06-05 | 업그레이드 | UBS | Neutral → Buy |
| 2023-11-28 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2023-11-03 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-10-31 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2023-10-13 | 개시 | Stifel | Hold |
| 2023-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2023-04-27 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-04-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | 개시 | Citigroup | Buy |
| 2022-11-28 | 다운그레이드 | UBS | Neutral → Sell |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-07-28 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-15 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-04 | 업그레이드 | Redburn | Sell → Neutral |
| 2021-06-09 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | 개시 | Barclays | Overweight |
| 2020-07-29 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-11-21 | 개시 | Citigroup | Buy |
| 2019-11-12 | 개시 | Bernstein | Outperform |
| 2019-07-23 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-02-08 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-12-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | 재확인 | Canaccord Genuity | Buy |
| 2018-01-25 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-12-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | 개시 | Canaccord Genuity | Buy |
| 2017-02-27 | 다운그레이드 | Goldman | Buy → Neutral |
| 2017-01-19 | 개시 | HSBC Securities | Hold |
| 2016-12-08 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | 다운그레이드 | Berenberg | Buy → Hold |
| 2016-02-26 | 개시 | Cantor Fitzgerald | Hold |
모두보기
Smith Nephew Plc Adr 주식(SNN)의 최신 뉴스
Smith & Nephew plc (ADR) stock (US83175M2052): U.K. medtech group draws interest after recent debt m - AD HOC NEWS
Smith & Nephew (NYSE: SNN) execs add ADS via dividend reinvestment - Stock Titan
Wound Irrigation Systems Market to Skyrocket USD 430.05 Million by 2035 as Chronic Wound Cases and Surgical Volumes Rise Worldwide | SNS Insider - GlobeNewswire Inc.
Dell Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact - Sahm
Smith & Nephew plc stock (GB0009223206): orthopedics specialist lifts guidance after solid Q1 - AD HOC NEWS
Smith & Nephew stock (GB0009223206): sets sterling final dividend ahead of May payout - AD HOC NEWS
Smith & Nephew stock (GB0009223206): +2.75% gain to 1,103 GBX - AD HOC NEWS
DowngradesStock ScreenerSnapshot - Finviz
Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,* - Sahm
New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years - ChartMill
Smith & Nephew plc (ADR) stock (US83175M2052): Why Google Discover changes matter more now for medte - AD HOC NEWS
Smith & Nephew plc (ADR) stock (US83175M2052): Why its medtech innovation edge is suddenly worth a c - AD HOC NEWS
Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing - ChartMill
Smith & Nephew plc (ADR) Stock: Global Medtech Leader Faces Evolving Orthopedics and Sports Medicine - AD HOC NEWS
Smith & Nephew plc (ADR) stock faces pressure amid regulatory hurdles and slowing ortho demand - AD HOC NEWS
Smith & Nephew plc (ADR) Stock (ISIN: US83175M2052) Faces Headwinds Amid Medtech Sector Slowdown - AD HOC NEWS
Smith+Nephew launches next-generation ALLEVYN COMPLETE CARE Foam Dressingdesigned for high performance in wound management and pressure injury prevention - Finviz
Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressingdesigned for high performance in wound management and pressure injury prevention - ChartMill
NVIDIA Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026 - Sahm
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026 - Sahm
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026 - Finviz
Smith & Nephew FTSE Healthcare Market Presence and Operational Developments - Kalkine Media
Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC) to our surgeons - Finviz
Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons - Sahm
Smith+Nephew signs distribution agreement with SI-BONE - Finviz
Factory Mutual Insurance Co. Buys New Stake in Smith & Nephew SNATS, Inc. $SNN - Defense World
Smith & Nephew (NYSE: SNN) leaders add ADS via plan - Stock Titan
Jim Cramer on Smith & Nephew: "This Group, I Do Not Like" - Finviz
Jim Cramer on Smith & Nephew: “This Group, I Do Not Like” - Insider Monkey
Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair - Finviz
The Truth About Smith & Nephew plc: Why This ‘Boring’ Med-Tech Stock Might Be Your Sneaky Power - AD HOC NEWS
Smith & Nephew ADR trying to close in on key technical benchmark - MSN
The Truth About Smith & Nephew plc (ADR): Wall Street Sleeper Stock or Total Snooze? - AD HOC NEWS
Smith & Nephew plc (ADR): Quiet Charts, Cautious Optimism – Is SNN a Sleeper in Medtech? - AD HOC NEWS
Smith Nephew Plc Adr (SNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):